Cargando…
Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179848/ https://www.ncbi.nlm.nih.gov/pubmed/33082513 http://dx.doi.org/10.1038/s41375-020-01060-w |
_version_ | 1783703876130570240 |
---|---|
author | Liu, Jin Hu, Xiaoxia Jia, Yanchun Lu, Jin Lee, Jae Hoon Kim, Kihyun Chen, Wenming Liu, Aijun Liu, Yang Chen, Qi Zhang, Chunyang Suh, Cheolwon Kim, Min Kyoung Zhou, Fan Chng, Wee Joo Kumar, Shaji K. Durie, Brian Hou, Jian Fu, Weijun Du, Juan |
author_facet | Liu, Jin Hu, Xiaoxia Jia, Yanchun Lu, Jin Lee, Jae Hoon Kim, Kihyun Chen, Wenming Liu, Aijun Liu, Yang Chen, Qi Zhang, Chunyang Suh, Cheolwon Kim, Min Kyoung Zhou, Fan Chng, Wee Joo Kumar, Shaji K. Durie, Brian Hou, Jian Fu, Weijun Du, Juan |
author_sort | Liu, Jin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8179848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81798482021-06-17 Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) Liu, Jin Hu, Xiaoxia Jia, Yanchun Lu, Jin Lee, Jae Hoon Kim, Kihyun Chen, Wenming Liu, Aijun Liu, Yang Chen, Qi Zhang, Chunyang Suh, Cheolwon Kim, Min Kyoung Zhou, Fan Chng, Wee Joo Kumar, Shaji K. Durie, Brian Hou, Jian Fu, Weijun Du, Juan Leukemia Letter Nature Publishing Group UK 2020-10-20 2021 /pmc/articles/PMC8179848/ /pubmed/33082513 http://dx.doi.org/10.1038/s41375-020-01060-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Liu, Jin Hu, Xiaoxia Jia, Yanchun Lu, Jin Lee, Jae Hoon Kim, Kihyun Chen, Wenming Liu, Aijun Liu, Yang Chen, Qi Zhang, Chunyang Suh, Cheolwon Kim, Min Kyoung Zhou, Fan Chng, Wee Joo Kumar, Shaji K. Durie, Brian Hou, Jian Fu, Weijun Du, Juan Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title_full | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title_fullStr | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title_full_unstemmed | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title_short | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) |
title_sort | clinical features and survival outcomes in igd myeloma: a study by asia myeloma network (amn) |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179848/ https://www.ncbi.nlm.nih.gov/pubmed/33082513 http://dx.doi.org/10.1038/s41375-020-01060-w |
work_keys_str_mv | AT liujin clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT huxiaoxia clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT jiayanchun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT lujin clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT leejaehoon clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT kimkihyun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT chenwenming clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT liuaijun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT liuyang clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT chenqi clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT zhangchunyang clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT suhcheolwon clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT kimminkyoung clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT zhoufan clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT chngweejoo clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT kumarshajik clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT duriebrian clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT houjian clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT fuweijun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn AT dujuan clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn |